Four years ago, Italy’s medicines regulator AIFA placed ... The ECJ also concluded that AIFA was qualified to monitor the off-label use of Avastin, and that the repackaging did not significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback